Stefaan Verhulst

Stefaan Verhulst is a Postdoctoral Researcher at the Flow Cytometry Core Facility within the Basic (bio-) Medical Sciences unit at Vrije Universiteit Brussel (VUB), Belgium. His work centers on liver disease mechanisms with emphasis on fibrosis, hepatic stellate cell biology, and stem cell-based modeling approaches.

His research integrates advanced cellular models including iPSC-derived liver organoids and precision-cut liver slices with single-cell genomic techniques to investigate liver fibrosis progression, drug-induced injury, and cellular communication pathways. Key focus areas include biomarker discovery for liver cirrhosis, stem cell differentiation protocols, and bioinformatic analysis of disease mechanisms across multiple etiologies.

With 89 research outputs showing accelerating productivity (21 publications in 2022 alone), his work demonstrates significant translational impact in hepatology. Current projects address anti-fibrotic therapies, flow cytometry infrastructure development, and educational leadership through the EUTOPIA consortium.

Dr. Verhulst actively supervises students as evidenced by PhD committee memberships and 'Supervised Work (2)' documentation. His grant portfolio includes three active projects demonstrating sustained funding success in both basic and applied research domains.

As director of the Flow Cytometry Core Facility, he provides critical cell analysis services to the VUB research community while advancing his own work on liver disease models. His international collaborations span multiple countries as visualized in the institutional network map.